Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

141 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Not Yet Recruiting

Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets

NCT07172126

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • Cancer Hospital Affiliated to Chongqing University Chongqing, Chongqing Municipality, China
  • The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China
  • Cancer Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Completed

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT05005728

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
View all 26 locations
View Trial Details
Completed

A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)

NCT06104449

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • National Cancer Center Hospital East ( Site 0001) Kashiwa, Chiba, Japan
  • Toho University Sakura Medical Center ( Site 0003) Sakura, Chiba, Japan
  • Yokohama City University Medical Center ( Site 0002) Yokohama, Kanagawa, Japan
View Trial Details
Completed

A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)

NCT06136598

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Peking University First Hospital-Urology ( Site 0001) Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center-Neurosurgery department ( Site 0003) Guangzhou, Guangdong, China
  • Tongji Hospital Tongji Medical,Science & Technology ( Site 0002) Wuhan, Hubei, China
View Trial Details
Completed

Study of INKmune in Patients With mCRPC (CaRe Prostate)

NCT06056791

Conditions
Cancer, MCRPC, Metastatic Castration-resistant Prostate Cancer, +1 more
Locations
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • Carl & Edyth Lindner Center for Research and Education at The Christ Hospital and The Christ Hospital Cancer Center Cincinnati, Ohio, United States
View Trial Details

Related conditions